Free radicals during HIV infection;RADICAUX LIBRES ET INFECTION PAR LE VIH

Annales de Biologie Clinique

Volumn 55, Issue 6, 1997, Pages 565-571

  Rabaud, Ch ^a   Tronel, H ^a   Fremont, S ^a   May, T ^a   Canton, P ^a   Nicolas, J P ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

AIDS; Apoptosis; Free radicals; HIV; Lipid peroxidation

Indexed keywords

ALPHA TOCOPHEROL; FREE RADICAL; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; POLYUNSATURATED FATTY ACID; SELENIUM; SUPEROXIDE; SUPEROXIDE DISMUTASE;

CHRONIC INFLAMMATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE; MYCOPLASMA; PHAGOCYTE; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIOXIDANTS; APOPTOSIS; FREE RADICALS; HIV INFECTIONS; HUMANS; REACTIVE OXYGEN SPECIES;

HUMAN IMMUNODEFICIENCY VIRUS; MYCOPLASMA; MYCOPLASMA SP.;

EID: 0030832660     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Favier A. Le stress oxydant : intérêt de sa mise en évidence en biologie médicale et problèmes posés par le choix d'un marqueur. Ann Biol Clin 1997 ; 55 : 9-16.
2. Scott MD, Lubin BH, Zuo L, Kuypers FA. Erythrocyte defense against hydrogen peroxide : preeminent importance of catalase. J Lab Clin Med 1991 ; 118 : 7-16.
3. Wefers H, Sies H. The protection by ascorbate and glutathione against microsomal lipid peroxidation is dependant on vitamin E. Eur J Biochem 1988 ; 174 : 353-7.
4. Murrell GAC, Francis MJO, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 1990 ; 265 : 659-65.
5. Greenspan HC. The role of reactive oxygen species, anti-oxidants and phytopharmaceuticals in human immunodefiency virus activity. Med Hypotheses 1993 ; 40 : 85-92.
6. Elbim C, Prevot MH, Bouscarat F, et al. PMN from HIV-infected patients show enhanced activation, diminished fmlp-induced L-selectin shedding and an impaired oxidative burst after cytokine priming. Blood 1994 ; 84 : 2759-66.
7. Guillard O, Sonnet J, Lauwerys R. Reactive oxygen species production in whole blood from aids patients. Clin Chim Acta 1989 ; 185 : 113-4.
8. Montagnier L, Blanchard A. Mycoplasmas as cofactors in infection due to the human immunodeficiency virus. Clin Inf Dis 1993 ; 17 : S309-15.
9. Javier JJ, Fodyce-Baum MK. Antioxidant micronutrients and immune function in HIV infection. FASEB J Proc 1990 ; 4 : A940.
10. Rabaud C, Maignan M, Amiel C, Alfandari S, May T, Canton P. Dénutrition et infection par le VIH. Rev Med Interne 1996 ; 17 : 992-1002.
11. Peuchant E, Delmas-Beauvieux MC, Constans J, Dubourg J, Thomas MJ. Preliminary results of a supplementation with β-carotene and selenium on lipoperoxydation in HIV-infected patients. First International Conference Nutrition and HIV infection, Cannes 28-29 avril 1995, P050.
12. 1 infected homosexual men. Am J Epidemiol 1993 ; 138 : 937-51.
13. Eck HP, Mertens T, Rosokat H, et al. T4+ cell numbers are correlated with plasma glutamate and cystine levels : association of hyperglutamataemia with immunodeficiency in diseases with different aetiologies. Int Immunol 1992 ; 4 : 7-13.
14. Repetto M, Reides C, Gomez Carretero ML, Costa M, Griemberg G, Llesuy S. Oxidative stress in blood of HIV infected patients. Clin Chim Acta 1996 ; 255 : 107-17.
15. Gmunder H, Eck HP, Dröge W. Low membrane transport activity for cystine in resting and mitogenically stimulated human lymphocyte preparations and human T-cells clones. Eur J Biochem 1991 ; 201 : 113-7.
16. Halliwell B, Cross CE. Reactive oxygen species, antioxidants, and acquired immunodeficiency syndrome. Arch Intern Med 1991 ; 151 : 29-31.
17. Israel N, Gougerot-Pocidalo MA, Aillet F, Virelizier JL. Redox status of cells influences constitutive or induced NF-kb translocation and HIV long terminal repeat in human R and monocytic cell lines. J Immunol 1992 ; 149 : 3386-93.
18. Staal FJT, Roederer M, Raju PA, Anderson M, Ela SW, Herzenberg LA. Antioxidants inhibit stimulation of HIV transcription. AIDS Res Human Retroviruses 1993 ; 9 : 299-306.
19. Roederer M, Staal FJT, Anderson M, Rabin R, Raju PA, Herzenberg LA. Disregulation of leukocyte glutathione in AIDS. Ann N Y Acad Sci 1993 ; 677 : 113-25.
20. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994 ; 15 : 7-10.
21. Christeff N, Lortholary O, Casassus PH, Thobie N, Dalle MT, Guillevin L, Nunez EA. Serum lipid concentrations with reference to the clinical and immunological progression of the HIV infection. First International Conference Nutrition and HIV infection, Cannes 28-29 avril 1995, P093.
22. Sonnerborg A, Carlin G, Akerlund B, Jarstrand C. Increased production of malondialdehyde in patients with HIV infection. Scand J Infect Dis 1988 ; 20 : 287-90.
23. Lopez O, Bonnefont-Rousselot D, Mollereau M, et al. Increased plasma thiobarbituric acid-reactive substances (TBARS) before opportunistic infection symptoms in HIV infected individuals. Clin Chim Acta 1996 ; 247 : 181-7.
24. Favier A, Sappey C, Leclerc P, Faure P, Micoud M. Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Interact 1994 ; 91 : 165-80.
25. Malvy DJM, Richard MJ, Arnaud J, Favier A, Amedee-Manesme O. Relationship of plasma malondialdehyde, vitamin E and antioxidant micronutriments to human immunodeficiency virus-1 seropositivity. Clin Chim Acta 1994 ; 224 : 89-94.
26. Orrenius S, McConkey DJ, Bellomo G, Nicotera P. Role of Ca in toxic cell killing. TIPS 1989 ; 10 : 281-5.
27. Ramakrishnan N, Catravas G. N-(2-mercaptoethyl)-1,3 propanediamine (WR-1065) protects thymocytes from programmed cell death. J Immunol 1992 ; 148 : 1817-21.
28. Hockenberry DM, Oltvai ZN, Yin XM, Milliman CL, Korsemeyer SJ. Bcl2 functions in an antioxydant pathway to prevent apoptosis. Cell 1993 ; 75 : 241-51.
29. Kalayjian RC, Skowron G, Emgushov RT, et al. A phase I/II trial of intravenous procysteine in asymptomatic HIV infected subjects. J Acquir Immunodef Synd 1994 ; 7 : 369-74.
30. Prochaska HJ, Yeh Y, Baron P, Polsky B. Oltipraz, an inhibitor of HIV1 replication. Proc Natl Acad Sci 1993 ; 90 : 3953-7.